← Back to Analyst Consensus 
ACRS Buy
Aclaris Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 19
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 1, 2026 | Canaccord Genuity | initiate | — → Buy | — | 48% |
| Jun 2, 2026 | LifeSci Capital | initiate | — → Outperform | — | 57% |
| May 5, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| May 5, 2026 | Guggenheim | initiate | — → Buy | — | 52% |
| Apr 29, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| Apr 16, 2026 | Oppenheimer | initiate | — → Outperform | — | 52% |
| Mar 31, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Mar 19, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jan 28, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Jan 21, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Oct 20, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Jun 25, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| May 28, 2025 | Wedbush | initiate | — → Outperform | $8 | 58% |
| May 14, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $16 | 44% |
| May 9, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $9 | 55% |
| Mar 18, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $0 | 50% |
| Mar 7, 2025 | Scotiabank | initiate | — → Sector Outperform | $15 | 55% |
| Dec 23, 2024 | HC Wainwright & Co. | upgrade | Neutral → Buy | $20 | 44% |
| Nov 19, 2024 | Leerink Partners | upgrade | Market Perform → Outperform | $7 | 51% |
| Nov 19, 2024 | Jefferies | upgrade | Hold → Buy | $7 | 52% |
| Nov 19, 2024 | BTIG | upgrade | Neutral → Buy | $8 | 52% |
| Nov 18, 2024 | Piper Sandler | upgrade | Neutral → Overweight | $13 | 54% |
| Sep 17, 2024 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
| Aug 19, 2024 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
| Jul 22, 2024 | HC Wainwright & Co. | reiterate | — → Neutral | $0 | 44% |
| Jan 22, 2024 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| Jan 11, 2024 | BTIG | downgrade | Buy → Neutral | $0 | 52% |
| Dec 29, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Dec 18, 2023 | Stifel | maintain | Hold → Hold | $1 | 53% |
| Nov 14, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $9 | 44% |
| Nov 14, 2023 | Cantor Fitzgerald | downgrade | Overweight → Neutral | $0 | 50% |
| Nov 13, 2023 | Stifel | downgrade | Buy → Hold | $2 | 53% |
| Nov 13, 2023 | William Blair | downgrade | Outperform → Market Perform | $0 | 48% |
| Oct 9, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $38 | 50% |
| Oct 4, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $43 | 44% |
| Oct 3, 2023 | Evercore ISI Group | initiate | — → Outperform | $22 | 58% |
| Sep 19, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $38 | 50% |
| Sep 19, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $43 | 44% |
| Sep 14, 2023 | Stifel | maintain | Buy → Buy | $20 | 53% |
| Aug 8, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $43 | 44% |
| Jun 14, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $43 | 44% |
| Mar 7, 2023 | Goldman Sachs | maintain | — → Buy | $21 | 54% |
| Mar 7, 2023 | BTIG | maintain | — → Buy | $29 | 52% |
| Mar 7, 2023 | HC Wainwright & Co. | maintain | — → Buy | $43 | 44% |
| Feb 24, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $50 | 44% |
| Feb 7, 2023 | Cantor Fitzgerald | reiterate | — → Overweight | $38 | 50% |
| Dec 14, 2022 | Stifel | initiate | — → Buy | $29 | 53% |
| Dec 1, 2022 | Goldman Sachs | initiate | — → Buy | $25 | 54% |
| Oct 6, 2022 | BTIG | initiate | — → Buy | $32 | 52% |
| Jun 16, 2021 | HC Wainwright & Co. | maintain | — → Buy | $50 | 44% |
Price Target Trend
Apr 21, 2026 Oct 26, 2026
EPS Estimates
+1q —
0y —
+1y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days